KOSDAQMachinery163280

Airrane

₩3,845▼ 0.39%2026-10-02 close
Market Cap
₩52.2B
Turnover
₩100M
Volume
30,000 shares
Shares out.
13.6M
PER
3.2×
PBR
—
EPS
₩1,109
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩0 per share · Prices as of the 2026-10-02 close

01

Report overview

Sole Membrane Maker Faces Scrutiny Amid Profit Surge

Airrane, Korea's only gas separation membrane solution provider, swung from a 2023 net loss to profitability in 2024-2025 and posted a sharp net income jump in Q2 2026, but standalone H1 revenue and operating profit actually declined, leaving the quality of growth to be verified.

  1. 1

    2025 consolidated revenue of KRW 28.08bn and operating profit of KRW 3.09bn (11.0% margin), improved from the prior year

  2. 2

    H1 2026 standalone revenue of KRW 13.97bn, down 6.1% year-on-year, mainly due to a sharp drop in system sales

  3. 3

    Airrane holds membrane manufacturing technology possessed by only a handful of companies worldwide, supplying nitrogen generation, biogas upgrading and CCUS markets

  4. 4

    Mid-to-long-term capacity expansion underway including the Cheongju No.2 plant and a new ionomer recycling business

  5. 5

    The Q2 2026 net income increase far outpaced operating profit, likely reflecting non-operating factors that warrant further confirmation

02

Business structure

Founded in 2001, Airrane develops, manufactures and sells gas separation membrane products using polymer-based hollow fiber technology, and listed on KOSDAQ in 2024 as a technology growth company.

Using its proprietary membrane, the company supplies modules and systems that separate nitrogen, methane and carbon dioxide at high purity, applied to nitrogen generation, biogas upgrading and carbon capture.

It holds a unique domestic position in a supplier-favored global market where only five companies directly manufacture and sell gas separation membranes.

Revenue is composed of membrane module sales and system (equipment) sales; modules tend to generate recurring revenue while system sales show large quarterly volatility due to accounting recognition upon completion of long-term construction contracts.

Domestic and overseas energy companies including the China Coal Research Institute, Korea Gas Corporation and Korea Hydro & Nuclear Power use its nitrogen generation solutions, while Lotte Chemical operates a CO2 capture system supplied by Airrane.

Strategic investors holding a combined 21.8% stake post-IPO include Series A investors Lotte Chemical, POSCO Investment and HL D&I Halla, and Series B investors SK Innovation and SK IE Technology, aiming to expand captive revenue through collaboration.

China accounts for more than half of total revenue, making regional demand trends highly influential on results.

New businesses include recovering and regenerating spent ionomer for supply to hydrogen vehicle and ESS membrane makers, and liquefying captured CO2 for supply to fresh food distributors, home shopping companies and shipbuilders.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q2₩8.9B₩1.1B12.4%
2025Q3₩6B₩500M8.1%
2025Q4₩7.2B₩300M4.8%
2026Q1₩6.3B₩1.2B18.3%
2026Q2₩7.6B₩800M10.8%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2023₩16.3B₩200M-₩15.1B1.5%−44.2%32.7%
2024₩24.5B₩1.9B₩2B7.6%3.1%28.8%
2025₩28.1B₩3.1B₩2.8B11.0%4.1%61.7%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-09-05

04

Earnings analysis

On a consolidated basis, despite 2023 revenue of KRW 16.34bn and operating profit of KRW 0.24bn (1.5% margin), the company posted a net loss of KRW 15.06bn, which appears to reflect a large one-off item outside core operations.

In 2024, revenue rose to KRW 24.50bn (7.6% operating margin) and net income turned positive at KRW 1.98bn, marking a swing from loss to profit, and in 2025 profit recovery continued with revenue of KRW 28.08bn, operating profit of KRW 3.09bn (11.0% margin) and net income of KRW 2.80bn.

By quarter, Q3 2025 revenue was KRW 6.01bn with operating profit of KRW 0.49bn, and Q4 2025 revenue was KRW 7.18bn with operating profit of KRW 0.35bn, showing revenue growth alongside a somewhat softer operating margin.

In Q1 2026, revenue was KRW 6.34bn with operating profit of KRW 1.16bn, a marked margin improvement, and net income rose to KRW 1.78bn.

In Q2 2026, revenue was KRW 7.63bn and operating profit KRW 0.83bn, while net income surged to KRW 4.09bn, a scale far exceeding the operating profit increase, suggesting a substantial non-operating factor whose precise cause requires checking the footnotes of the quarterly filing.

On a standalone basis, the company reported H1 2026 revenue of KRW 13.97bn and operating profit of KRW 1.98bn, down 6.1% and 12.0% year-on-year respectively, which management attributed to higher export logistics costs and accounting timing shifts in system-sales revenue recognition.

Module sales grew year-on-year on new customer additions, but the decline was driven largely by system sales falling by nearly half. CEO Ha Seong-yong said he expects a second-half earnings recovery based on module sales growth momentum and new order activity.

05

Industry analysis

Gas separation membrane technology is a high-barrier industry held by only a small number of companies globally, used to selectively separate gases such as nitrogen, carbon dioxide and methane.

Domestically, the Biogas Promotion Act, enacted in 2023 and expanding enforcement from the public sector in 2025 to the private sector in 2026, requires organic waste treatment operators to install biogas upgrading facilities, building a demand base for related equipment.

Carbon capture, utilization and storage (CCUS) is expected to expand on the back of tightening regulation, including domestic carbon neutrality policy and discussions around the European Union's carbon border tax.

Competing technologies include cryogenic separation, adsorption and absorption methods, with membrane technology considered to have a relative edge in eco-friendliness and equipment efficiency.

The Alaska LNG project, amid repeated US requests for Korean participation, has drawn market attention as a related carbon capture and LNG equipment theme, though the project's final investment decision and timing remain unconfirmed.

Industry observers note that the gas membrane market continues to be characterized by a structurally supplier-favored dynamic due to the small number of producers.

06

Outlook

Airrane has been remodeling and expanding equipment at its Cheongju No.2 plant to bring it online, and is pursuing a plan to expand gas membrane module production capacity in stages from 20,000 units in 2024 to 40,000 in 2025 and 60,000 in 2026, according to a December 2025 report from Korea Investment & Securities.

The same report noted that ionomer recycling production capacity is planned to expand in stages from 0.5 tons in 2026 to 3 tons in 2027 and 6 tons in 2028.

The company said it is working with local governments and hydrogen ecosystem operators to build biogas upgrading plants and CO2 capture-liquefaction facilities for hydrogen-producing steam methane reformers, and is developing a new biogas upgrading product it aims to launch to market within the year.

CEO Ha Seong-yong previously stated in a media interview a goal of achieving five-fold revenue growth within five years through membrane technology innovation.

The company followed through on a listing-time pledge to retire all treasury shares once escrow was lifted, and carried out a 100% bonus share issuance in early 2026 to expand the number of shares outstanding.

How quickly these mid-to-long-term plans convert into actual revenue, however, remains something to be verified through second-half and future quarterly results.

07

Valuation

PER
3.2×
PBR
—
ROE
10.8%
EPS
₩1,109
BPS
—
Dividend per share
₩0

The company swung from a net loss in 2023 to profitability in 2024-2025, and headline net income has grown further in recent quarters, suggesting an improvement in surface-level profitability metrics.

However, a substantial portion of the recent quarterly net income increase appears to have exceeded the growth in operating profit by a wide margin, indicating a possible non-operating factor whose recurrence may be limited.

The stock trades at a level below net asset value per share, and the company has not paid dividends, so there is no accumulated track record of shareholder returns through dividends.

Since listing, there have been several changes to the capital structure, including a bonus share issuance, treasury share retirement, and convertible bond/bond-with-warrant issuance, so per-share metrics should be compared across time with these events in mind.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-09-05

08

Bull factors

Supplier-Favored Market Position Amid Regulatory Tailwinds

Building on membrane manufacturing technology held solely in Korea and by only a handful of companies worldwide, the expanded private-sector enforcement of the Biogas Promotion Act and domestic/international carbon neutrality policies are broadening the demand base.

Because the market itself is structured around a small number of suppliers, the company may hold a relatively favorable position in pricing and contract negotiations. There is also room to expand captive revenue through collaboration with large corporations that participated as strategic investors.

Capacity Expansion and Business Diversification

The Cheongju No.2 plant is operating with a phased capacity expansion plan underway, and new revenue sources such as the ionomer recycling business are being added. Product diversification efforts, including a CO2 liquefaction plant and a new biogas upgrading product, aim to reduce reliance on a single business line.

Track Record of Shareholder-Friendly Actions

The company followed through on a listing-time pledge to retire treasury shares once the escrow lockup was lifted, and carried out a bonus share issuance aimed at expanding shares outstanding and improving trading liquidity. These actions could serve as a basis for confidence in additional shareholder return policies going forward.

09

Bear factors

Volatility in Core Business Revenue

In H1 2026, standalone revenue and operating profit both declined year-on-year, driven largely by a sharp drop in system sales, which are recognized upon completion of long-term contracts. This can reduce the predictability of quarterly results.

The higher logistics costs cited by the company are also a cost factor that could recur given the export-heavy business structure.

Questions Around Earnings Quality

Both the 2023 case of a large net loss despite positive operating profit and the Q2 2026 case where net income growth far outpaced operating profit growth suggest significant volatility in non-operating items. If such non-operating gains or losses recur or reverse, the earnings trajectory could swing considerably.

Uncertainty Around New Business Commercialization Timing

The ionomer recycling business and large-scale CCUS commercialization remain largely in an early or pilot stage, and the timing and pace at which planned production expansion translates into actual revenue are not yet confirmed.

The new biogas upgrading product is also at a stage where market reception needs to be observed after its targeted launch.

10

Risk factors

Customer and Regional Concentration Risk

China accounts for more than half of revenue, so changes in that region's industrial demand, tariffs, and trade environment can directly affect results. A system-sales structure centered on specific large projects also increases volatility from customer concentration.

Competing Technology Risk

The CO2/nitrogen separation market includes alternative technologies such as cryogenic separation, adsorption, and absorption, which can be more competitive than membrane technology for certain applications or price conditions.

The competitive landscape could shift depending on the technology investment direction of large global industrial gas companies.

Capital Structure and Financial Volatility Risk

The issuance of KRW 20bn in convertible bonds and bonds with warrants creates potential future share dilution, and fair value valuation of these financial instruments can cause large swings in net income. Small market capitalization and low liquidity can also amplify share price volatility.

11

What to watch next

  1. Mid-November 2026

    Check the Q3 quarterly report for whether the second-half earnings recovery materializes and whether system sales normalize.

  2. Q4 2026

    Confirm whether the company's targeted new biogas upgrading product actually launches to market and gauge initial reception.

  3. Late 2026 to early 2027

    Review whether the ionomer recycling business begins reflecting initial production and revenue, and check progress on Cheongju No.2 plant capacity expansion.

  4. During 2026

    Continue monitoring news on whether the Alaska LNG project reaches a final investment decision (FID) and on Korean corporate participation.

  5. Early 2027

    Check whether the specific cause of the Q2 2026 net income surge is clearly disclosed in the footnotes of the annual business report.

12

Overall view

Airrane is a KOSDAQ-listed company holding gas separation membrane manufacturing technology unique in Korea, having swung from a net loss in 2023 to profitability in 2024-2025, with net income increasing sharply in recent quarters.

However, H1 2026 standalone revenue and operating profit both declined year-on-year, and the fact that Q2 2026 net income growth far outpaced operating profit growth suggests a possible non-operating factor whose sustainability requires verification.

The expanded enforcement of the Biogas Promotion Act and CCUS-related policy direction could form a mid-to-long-term demand base, and new growth drivers such as the Cheongju No.2 plant expansion and the ionomer recycling business are being prepared.

At the same time, dependence on China-related revenue, competition from alternative technologies, and potential dilution risk from convertible bonds and bonds with warrants are factors that should be weighed in balance.

Changes in the quarterly revenue mix between modules and systems, and the actual pace at which new businesses convert into revenue, appear to be the key points to watch in verifying the company's growth story going forward.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. asiae.co.kr
  2. asiae.co.kr
  3. comp.fnguide.com
  4. airrane.com
  5. thevc.kr
  6. finance.finup.co.kr
  7. shinyoung.com
  8. comp.fnguide.com
  9. sedaily.com
  10. newspim.com
  11. judal.co.kr
  12. judal.co.kr
  13. kind.krx.co.kr
  14. comp.wisereport.co.kr
  15. digitaltoday.co.kr
  16. news.nate.com
  17. investing.com
  18. file.alphasquare.co.kr

Report written 2026-09-05 · Data as of 2026-09-04

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.